| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation Date | 2014-08-30 21:03:55 UTC |
|---|
| Update Date | 2016-11-09 01:09:09 UTC |
|---|
| Accession Number | CHEM003516 |
|---|
| Identification |
|---|
| Common Name | Guaifenesin |
|---|
| Class | Small Molecule |
|---|
| Description | An expectorant that also has some muscle relaxing action. It is used in many cough preparations. [PubChem] |
|---|
| Contaminant Sources | - FooDB Chemicals
- HPV EPA Chemicals
- STOFF IDENT Compounds
- T3DB toxins
- ToxCast & Tox21 Chemicals
|
|---|
| Contaminant Type | - Amine
- Drug
- Ether
- Expectorant
- Food Toxin
- Organic Compound
- Synthetic Compound
|
|---|
| Chemical Structure | |
|---|
| Synonyms | | Value | Source |
|---|
| Hustosil | Kegg | | Robitussin | Kegg | | 3-(2-Methoxyphenoxy)-1,2-propanediol | HMDB | | 3-(O-Methoxyphenoxy)-1,2-propanediol | HMDB | | 3-(O-Methoxyphenoxy)-propanediol-1,2 | HMDB | | 3-O-Methoxyphenoxypropane 1:2-diol | HMDB | | a-Glyceryl guaiacol ether | HMDB | | a-Glyceryl guaiacolate ether | HMDB | | Actifed C | HMDB | | Aeronesin | HMDB | | alpha-Glyceryl guaiacol ether | HMDB | | alpha-Glyceryl guaiacolate ether | HMDB | | Amonidren | HMDB | | Amonidrin | HMDB | | Aresol | HMDB | | Benylin-e | HMDB | | Bronchol | HMDB | | Glycerin ether | HMDB | | Glycerin guaiacolate | HMDB | | Glycero-guaiacol ether | HMDB | | Glycerol a-(2-methoxyphenyl) ether | HMDB | | Glycerol a-(O-methoxyphenyl)ether | HMDB | | Glycerol a-guaiacyl ether | HMDB | | Glycerol a-guiacyl ether | HMDB | | Glycerol a-monoguaiacol ether | HMDB | | Glycerol guaiacolate | HMDB | | Glycerol mono(2-methoxyphenyl) ether | HMDB | | Glycerol-a-guajakolether | HMDB | | Glycerol-alpha-guajakolether | HMDB | | Glyceryl guaiacol | HMDB | | Glyceryl guaiacol ether | HMDB | | Glyceryl guaiacolate | HMDB | | Glyceryl guaiacolate ether | HMDB | | Glyceryl guaiacyl ether | HMDB | | Glyceryl guaicolate | HMDB | | Glyceryl guiacolate | HMDB | | Glycerylguaiacol | HMDB | | Guaiacol glycerol ether | HMDB | | Guaiacol glyceryl ether | HMDB | | Guaiacolglicerinetere | HMDB | | Guaiacuran | HMDB | | Guaiacurane | HMDB | | Guaiacyl glyceryl ether | HMDB | | Guaiamar | HMDB | | Guaianesin | HMDB | | Guaicol glycerine ether | HMDB | | Guaicol glyceryl ether | HMDB | | Guaifenesine | HMDB | | Guaiphenesin | HMDB | | Guaiphenesine | HMDB | | Guaiphesin | HMDB | | Methoxypropanediol | HMDB | | Methphenoxydiol | HMDB | | Metossipropandiolo | HMDB | | O-Methoxyphenyl glyceryl ether | HMDB | | Organidin NR | HMDB | | p-Cresyl acetate | HMDB | | Pneumomist | HMDB | | Propanosedyl | HMDB | | Reduton | HMDB | | Breonesin | HMDB | | Ether, guaiacol glyceryl | HMDB | | Glyceryl ether, guaiacol | HMDB | | Hytuss | HMDB | | Guaiphenezine | HMDB | | Humibid | HMDB | | Scott-tussin | HMDB | | Guaiacolate, glycerol | HMDB | | Guiatuss | HMDB | | Scott tussin | HMDB | | ScottTussin | HMDB |
|
|---|
| Chemical Formula | C10H14O4 |
|---|
| Average Molecular Mass | 198.216 g/mol |
|---|
| Monoisotopic Mass | 198.089 g/mol |
|---|
| CAS Registry Number | 93-14-1 |
|---|
| IUPAC Name | 3-(2-methoxyphenoxy)propane-1,2-diol |
|---|
| Traditional Name | guaifenesin |
|---|
| SMILES | COC1=CC=CC=C1OCC(O)CO |
|---|
| InChI Identifier | InChI=1S/C10H14O4/c1-13-9-4-2-3-5-10(9)14-7-8(12)6-11/h2-5,8,11-12H,6-7H2,1H3 |
|---|
| InChI Key | HSRJKNPTNIJEKV-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | belongs to the class of organic compounds known as anisoles. These are organic compounds containing a methoxybenzene or a derivative thereof. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Phenol ethers |
|---|
| Sub Class | Anisoles |
|---|
| Direct Parent | Anisoles |
|---|
| Alternative Parents | |
|---|
| Substituents | - Phenoxy compound
- Methoxybenzene
- Anisole
- Alkyl aryl ether
- Monocyclic benzene moiety
- Secondary alcohol
- 1,2-diol
- Ether
- Organic oxygen compound
- Hydrocarbon derivative
- Primary alcohol
- Organooxygen compound
- Alcohol
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Biological Properties |
|---|
| Status | Detected and Not Quantified |
|---|
| Origin | Exogenous |
|---|
| Cellular Locations | |
|---|
| Biofluid Locations | Not Available |
|---|
| Tissue Locations | Not Available |
|---|
| Pathways | Not Available |
|---|
| Applications | Not Available |
|---|
| Biological Roles | Not Available |
|---|
| Chemical Roles | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Appearance | White powder. |
|---|
| Experimental Properties | | Property | Value |
|---|
| Melting Point | 78.5-79°C | | Boiling Point | 215 °C at 1.90E+01 mm Hg | | Solubility | highly water-soluble |
|
|---|
| Predicted Properties | |
|---|
| Spectra |
|---|
| Spectra | | Spectrum Type | Description | Splash Key | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | splash10-02h9-9700000000-9c7025c23632b898d401 | Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (2 TMS) - 70eV, Positive | splash10-0fmi-9432000000-342d4da0e22ae9b9aeec | Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (TMS_1_1) - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (TMS_1_2) - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | Spectrum | | LC-MS/MS | LC-MS/MS Spectrum - LC-ESI-qTof , Positive | splash10-0hb9-2900000000-261d308d57fa6814ad4e | Spectrum | | LC-MS/MS | LC-MS/MS Spectrum - , positive | splash10-0hb9-2900000000-261d308d57fa6814ad4e | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0002-1900000000-27c5135862d6c8167c73 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-005a-5900000000-9b8da4dd94b7fb1f4514 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0a4i-9600000000-73302276ee78da40b353 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-006t-0900000000-0f11215eb276a39fd06b | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-05fr-1900000000-4b965972285b96b9e5dc | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0a4i-7900000000-4bcd84a8adc005d13314 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-004i-1900000000-eb412f483f86ec8f705d | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0a4i-9700000000-4723ff7a6d82ffc57f34 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0apj-9200000000-199acc3684b3ffda6264 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-00di-1900000000-b243c8d4b91c35158893 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0a4i-9700000000-d4d9707e69287ac032f6 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0a4i-9400000000-774a7e43dd3c0931c38f | Spectrum | | MS | Mass Spectrum (Electron Ionization) | splash10-00di-3900000000-022756bf476e39b7c0be | Spectrum | | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | | 2D NMR | [1H,13C] 2D NMR Spectrum | Not Available | Spectrum |
|
|---|
| Toxicity Profile |
|---|
| Route of Exposure | Rapidly absorbed from the GI tract |
|---|
| Mechanism of Toxicity | Guaifenesin may act as an irritant to gastric vagal receptors, and recruit efferent parasympathetic reflexes that cause glandular exocytosis of a less viscous mucus mixture. Cough may be provoked. This combination may flush tenacious, congealed mucopurulent material from obstructed small airways and lead to a temporary improvement in dyspnea or the work of breathing. |
|---|
| Metabolism | Rapidly hydrolyzed (60% within seven hours) and then excreted in the urine, with beta-(2-methoxyphenoxy)-lactic acid as its major urinary metabolite.
Half Life: 1 hour |
|---|
| Toxicity Values | Oral, Rat: LD50 1510 mg/kg |
|---|
| Lethal Dose | Not Available |
|---|
| Carcinogenicity (IARC Classification) | No indication of carcinogenicity to humans (not listed by IARC). |
|---|
| Uses/Sources | Used to assist the expectoration of phlegm from the airways in acute respiratory tract infections. |
|---|
| Minimum Risk Level | Not Available |
|---|
| Health Effects | Not Available |
|---|
| Symptoms | Not Available |
|---|
| Treatment | Not Available |
|---|
| Concentrations |
|---|
| Not Available |
|---|
| External Links |
|---|
| DrugBank ID | DB00874 |
|---|
| HMDB ID | HMDB0247133 |
|---|
| FooDB ID | FDB023575 |
|---|
| Phenol Explorer ID | Not Available |
|---|
| KNApSAcK ID | Not Available |
|---|
| BiGG ID | Not Available |
|---|
| BioCyc ID | Not Available |
|---|
| METLIN ID | 4057 |
|---|
| PDB ID | Not Available |
|---|
| Wikipedia Link | Guaifenesin |
|---|
| Chemspider ID | 3396 |
|---|
| ChEBI ID | 200157 |
|---|
| PubChem Compound ID | 3516 |
|---|
| Kegg Compound ID | Not Available |
|---|
| YMDB ID | Not Available |
|---|
| ECMDB ID | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Wilfred P. Shum, Harry Mazurek, Jian Chen, “Process for producing enantiomerically enriched guaifenesin.” U.S. Patent US5495052, issued August, 1949. |
|---|
| MSDS | Not Available |
|---|
| General References | |
|---|